Pfizer Inc (PFE) income statement
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3048% above fair value
$28.06−0.41 (-1.44%)
Close on Nov 18, 2026Market cap $159.93BP/E 36.9Yield 6.13%
Pfizer Inc income statement
Ratios
Latest available, balances at Jun 28, 2026
Profitability, TTM
- Gross margin
- 73.2%
- Operating margin
- –
- Net margin
- 6.8%
- Return on equity, FY2025
- 8.9%
Financial strength
- Current ratio
- 1.27
- Debt to equity
- 0.74
- Debt to assets
- 31.4%
- Cash to current liabilities
- 3.0%
Valuation
- P/E ratio
- 36.9
- Price to sales
- 2.51
- Price to book
- 1.88
- Dividend yield
- 6.13%
See a number that looks wrong?